Adaptive Biotechnologies(US:ADPT) Globenewswireยท2025-07-15 20:05Core Insights - Adaptive Biotechnologies Corporation will report its financial results for Q2 2025 on August 5, 2025, after market close [1] - A conference call will follow the financial results announcement, starting at 1:30 p.m. Pacific Time [1] Company Overview - Adaptive Biotechnologies is a commercial-stage biotechnology company focused on utilizing the adaptive immune system for disease diagnosis and treatment [3] - The company aims to decode the adaptive immune system's genetics to enhance medical capabilities in diagnosing and treating diseases [3] - Its proprietary immune medicine platform is designed to provide scalable, precise, and rapid insights into the adaptive immune system [3] - The company operates in two business segments: Minimal Residual Disease (MRD) and Immune Medicine, targeting diseases such as cancer and autoimmune disorders [3] - The goal is to develop and commercialize immune-driven clinical products tailored to individual patients [3]